Cell-Free Interrogation of Peptide and Small-Molecule Inhibitors of Protein-Protein Interactions
To determine the inhibition of the interactions between p53 and hDM2 or hDM4 duplicate 25 μL translation reactions were carried out in Rabbit Reticulocyte Lysate (Promega) according to the manufacturer's protocol using 0.4 pmols of either CFluc-hDM2 or CFluc-hDM4 mRNA and 2 pmols of p53-NFluc mRNA and 0.5 L of RNasin Plus (Promega) followed by an incubated at 30 °C for 90 minutes. Following incubation either (+)-nutlin-3 or (-)-nutlin-3 was added post-reassembly to a final concentration of 5 M and allowed to incubate for 30 minutes at room temperature. Inhibition was assayed by combining 10 L of translation solution with 40 L of Steady-Glo Luciferase Assay System (Promega). Light emission was monitored 1 minute after Steady-Glo addition using a Turner Biosystems 20/20 n Luminometer with a 3 second delay and a 10 second integration time.
Cell-Free Interrogation of Bcl-2 Family Inhibitors:
Separate 25 L translations were carried out in treated rabbit reticulocyte lysate using 0.4 pmols of either CFluc-Bcl-2 or CFluc-Bcl-x L mRNA and 2 pmols of BIM-NFluc mRNA and 0.5 L of RNasin Plus (Promega) followed by an incubated at 30 °C for 90 minutes. Following incubation 100 M BIM peptide or DMSO was allowed to incubate with CFluc-receptor translations for 20 minutes at room temperature followed by the subsequent addition of an equal volume of BIM-NFluc translation and incubation for an additional 20 minutes. Samples were assayed for luciferase activity by combining 10 L of translation solution with 40 L of Steady-Glo Luciferase Assay System (Promega). Light emission was monitored 1 minute after Steady-Glo addition using a Turner Biosystems 20/20 n Luminometer with a 3 second delay and a 10 second integration time.
Cell-Free Interrogation of Inhibitor Specificity
Separate 25 L translations were carried out in treated rabbit reticulocyte lysate using 0.4 pmols of each CFluc-receptor mRNA and 2 pmols of each Helix-NFluc mRNA being analyzed, and 0.5 L of RNasin Plus (Promega) followed by an incubated at 30 °C for 90 minutes. Following incubation 10 L of each CFlucreceptor translation being analyzed was incubated with 100 M of the small-molecule being analyzed or DMSO followed by a 20 minute incubation at room temperature. Subsequently, 10 L of either BIM-NFluc (for Bcl-2 family interactions) or p53-NFluc (for hDM2 and hDM4 interactions) translation was added followed by an additional 20 minute incubation at room temperature. For tethered luciferase control inhibition 25 L translations were carried out in treated rabbit reticulocyte lysate using 0.4 pmols mRNA and 0.5 L of RNasin Plus (Promega) followed by 30 °C for 90 minutes. Following translation, inhibitors were incubated with tethered luciferase translation for 40 minutes at room temperature. Samples were assayed for luciferase activity by combining 10 L of translation solution with 40 L of Steady-Glo Luciferase Assay System (Promega). Light emission was monitored 1 minute after Steady-Glo addition using a Turner Biosystems 20/20 n Luminometer with a 3 second delay and a 10 second integration time. Relative levels of inhibition were determined by comparison with assays containing no inhibitor.
Synthesis of ABT-263
Synthesis of ABT-263 was carried out as described by Wang et al 1 with several minor modifications of the experimental conditions. General Methods. Solvents and reagents were from Aldrich unless otherwise indicated and used without further purification. 1 H and 13 C NMR spectra were obtained on a Varian UNITY (300 MHz). Chemical shifts are reported as  values (ppm) downfield relative to TMS. Mass spectra were performed on JEOL HX110A. Column chromatography was carried out on silica gel (250 mesh). Some compounds were purified by preparative HPLC on a Varian Symmetry C18 column using 0.1% TFA in CH 3 CN/H 2 O at a flow rate of 8 mL/min.
Scheme 1.
Retrosynthesis of ABT-263 as previously described by Wang et al. [1] ABT-263(1) Scheme 5. Synthesis of 1, ABT-263, as described by Wang. [1, 9] 
Synthesis of Tert-Butyl 4-Piperazin

Synthesis of
Synthesis of 1-Nitro-2-[(trifluoromethyl)sulfonyl] benzene (9):
1,2-bis(2-Nitro phenyl) disulfide (6.16 g, 20 mmol) and CF 3 CO 2 K (6.08 g, 40 mmol) were dissolved in sulfolane (5 mL), and the resulting mixture was heated to 180ºC. The distilled yellow oil was collected under reduced pressure at 210ºC to give 9 (7.4 g) as a crude product, which was used without further purification. 1 Synthesis of 10: H 5 IO 6 (4.787 g, 10 mmol) was added to acetonitrile (60 mL) by vigorous stirring at room temperature for 30 min following which CrO 3 (100 mg, 1 mmol, 10 mol %) was adding to the solution. The mixture was stirred at room temperature for 5 min to give an orange solution (with some remaining white solid.) To this solution, 9 was added (2.23 g, 10 mmol, with CH 3 CN 5 mL) at room temperature. The reaction resulted in a white precipitate immediately. The mixture was stirred overnight, filtered, concentrated, dissolved in EtOAc, washed with saturated aqueous Na 2 SO 3 (the solution turned green from orange), and finally washed twice with brine, dried over Na 2 SO 4 and concentrated. The residue was purified by chromatography on silica gel (PE/EtOAc, 5:1) to provide 10. EI-MS: m/z = 254.98 [M] + .
Synthesis of 4-Fluoro-3-[(trifluoromethyl)sulfonyl] benzene (3):
Freshly dried KF (290.5 mg, 5 mmol), Ph 4 PBr (524.1 mg, 1.25 mmol), and 10 (637.5 mg, 2.5 mmol) were suspended in anhydrous DMSO (10 mL), and the resulting mixture was stirred at 130ºC for 15 min. After the mixture had been cooled to room temperature, H 2 O was added and the mixture was extracted, concentrated, and purified by silica gel (PE/EtOAc, 10:1). The mixture 11 was obtained, which was used for the next step without further purification.
11 (320 mg) was suspended in ClSO 3 H (1 mL) at 0 ºC, and the resulting mixture was heated under strirring at 95ºC for 18 h, and slowly cooled to room temperature. H 2 O (10 mL) was added drop wise to quench the reaction, and the mixture was extracted with EtOAc (2×50mL). The organic phases were combined, dried (Na 2 SO 4 ) and concentrated. The mixture 12 was used for the next step without further purification. NH 4 OH (2 mL) was added to the mixture above at 0ºC, and the resulting solution was stirred for 10 min. The mixture was neutralized with 2 M HCl at 0ºC, and extracted with EtOAc (3×100 mL). The organic phases were combined and dried (Na 2 SO 4 ). The solvent was removed under reduced pressure and the residue was purified by chromatography (silica gel, PE/EtOAc, 2:1). The product was purified by HPLC again [0-100% (40min), 0.1% TFA, ACN/H2O] to provide 120 mg of 3. 1 
Synthesis of (R)-3-(9H-Fluoren-9-yloxycarbonylamino)-4-hydroxybutyric Acid tert-Butyl Ester (13):
A solution of Fmoc-D-Asp(OtBu)-OH (1.5 g, 3.63 mmol) and DIPEA (0.77 mL) in THF (17 mL) at -40ºC was treated with isobutyl chloroformate (0.517 mL, 4.02 mmol), warmed to 0ºC over 30 min, cooled to -20ºC, and NaBH 4 (0.273 g, 7.27 mmol) in MeOH (10 mL) was added drop wise. The reaction was gradually warmed to room temperature over 2 h, diluted with EtOAc (33 mL), washed with water and brine, dried (Na 2 SO 4 ), filtered, concentrated, and purified by silica gel to provide 1.35 g (94%) of 13. 1 
Synthesis of (R)-3-(9H-Fluoren-9-yloxycarbonylamino)-4-phenylsulfanyl-butyric Acid tert-Butyl Ester (14):
A solution of Bu 3 P (0.4 mL, 1.62 mmol) was added to 1,1'-(azodicarbonyl) dipiperidine (420 mg, 1.66 mmol) in anhydrous THF (10 mL) at 0ºC and stirred for 30 min, when it turned colorless from yellow. Then 13 (310 mg, 0.78 mmol) and thiophenol (0.17 mL, 1.66 mmol) was added to the reaction mixture under Argon, stirred for 24 h, and concentrated. The concentrated was chromatographed on silica gel (EtOAc/hexanes, 1:10 to 1:4) to provide 265.5 mg (69.5%) of 14. 1 
